Warbington Timothy bought CELZ

Footnotes

The shares of common stock were issued to Creative Acquisition Corp. ("CAC") pursuant to a Stock Purchase Agreement dated September 24, 2026 (the "SPA"), between CAC and the Issuer, pursuant to which the Issuer purchased 4,000,000 shares of common stock of BioDefense, Inc. ("BioDefense") from CAC for a purchase price consisting of $200,000 in cash and 1,000,000 shares of the Issuer's common stock. After giving effect to the transactions under the SPA, the Issuer owns 80% (16,000,000) of the outstanding shares of BioDefense and CAC owns 20% (4,000,000) of the outstanding shares of BioDefense. Timothy Warbington is the Chairman and Chief Executive Officer of CAC, indirectly owns all of its outstanding shares of capital stock, and beneficially owns the shares held by CAC.; Amount of shares of the Issuer's common stock beneficially owned following the reported transaction consists of 12,209 shares owned by Timothy Warbington, 1,000,000 shares owned by CAC, and 22,695 shares owned by Creative Medical Health, Inc. ("CMH"). Mr. Warbington is the President of CMH, owns substantially all of its outstanding shares of common stock and beneficially owns the shares held by CMH.